Table 2 Association of tumor budding, cell cluster size, novel grade, and FIGO grade with clinicopathological parameters in EAC*.
Tumor budding score | p | Tumor cell cluster size score | p | Novel grade | P | FIGO grade | p | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 n = 264 | 2 n = 52 | 3 n = 82 | 1 n = 217 | 2 n = 47 | 3, n = 48 | 4 n = 86 | G1 n = 264 | G2 n = 28 | G3 n = 106 | G1 n = 291 | G2 n = 59 | G3 n = 48 | |||||
Age | 0.165 | 0.451 | 0.323 | 0.857 | |||||||||||||
≤46 yr | 154 | 28 | 37 | 127 | 27 | 24 | 41 | 154 | 14 | 51 | 162 | 32 | 25 | ||||
>46 yr | 110 | 24 | 45 | 90 | 20 | 24 | 45 | 110 | 14 | 55 | 129 | 27 | 23 | ||||
WHO type | <0.001 | <0.001 | <0.001 | 0.554 | |||||||||||||
HPVA | 220 | 38 | 36 | 180 | 40 | 36 | 38 | 220 | 22 | 52 | 220 | 40 | 34 | ||||
HPVI | 32 | 14 | 42 | 29 | 3 | 12 | 44 | 32 | 6 | 50 | 71 | 10 | 7 | ||||
Silva pattern** | <0.001 | <0.001 | <0.001 | <0.001 | |||||||||||||
A | 58 | 0 | 0 | 58 | 0 | 0 | 0 | 58 | 0 | 0 | 56 | 2 | 0 | ||||
B | 43 | 3 | 0 | 43 | 0 | 3 | 0 | 43 | 3 | 0 | 45 | 1 | 0 | ||||
C | 127 | 30 | 33 | 83 | 44 | 27 | 36 | 127 | 14 | 49 | 119 | 39 | 32 | ||||
Lymph node metastasis | <0.001 | <0.001 | <0.001 | 0.076 | |||||||||||||
Yes | 15 | 7 | 32 | 8 | 7 | 9 | 30 | 15 | 3 | 36 | 31 | 15 | 8 | ||||
No | 208 | 41 | 43 | 170 | 38 | 38 | 46 | 208 | 24 | 60 | 210 | 44 | 38 | ||||
Ovarian involvement | <0.001 | 0.002 | 0.001 | 0.56 | |||||||||||||
Yes | 2 | 2 | 8 | 2 | 0 | 2 | 8 | 2 | 2 | 8 | 10 | 2 | 0 | ||||
No | 241 | 49 | 71 | 197 | 44 | 45 | 75 | 241 | 25 | 95 | 259 | 57 | 45 | ||||
Lymphovascular invasion (LVI) | <0.001 | <0.001 | <0.001 | 0.024 | |||||||||||||
Yes | 56 | 33 | 76 | 30 | 26 | 33 | 76 | 56 | 15 | 94 | 109 | 33 | 23 | ||||
No | 208 | 19 | 6 | 187 | 21 | 15 | 10 | 208 | 13 | 12 | 182 | 26 | 25 | ||||
Perineural involvement (PNI) | <0.001 | <0.001 | <0.001 | 0.516 | |||||||||||||
Yes | 1 | 7 | 21 | 0 | 1 | 6 | 22 | 1 | 4 | 24 | 21 | 6 | 2 | ||||
No | 263 | 45 | 61 | 217 | 46 | 42 | 64 | 263 | 24 | 82 | 270 | 53 | 46 | ||||
Depth of invasion of cervical wall | <0.001 | <0.001 | <0.001 | 0.001 | |||||||||||||
≤1/3 | 76 | 2 | 0 | 72 | 4 | 2 | 0 | 76 | 2 | 0 | 69 | 6 | 3 | ||||
>1/3, ≤2/3 | 122 | 12 | 16 | 108 | 14 | 9 | 19 | 121 | 5 | 24 | 110 | 20 | 20 | ||||
å 2/3 | 65 | 37 | 64 | 36 | 29 | 37 | 64 | 65 | 22 | 79 | 108 | 33 | 25 | ||||
FIGO stage | <0.001 | <0.001 | <0.001 | 0.155 | |||||||||||||
I | 236 | 38 | 33 | 201 | 35 | 30 | 41 | 236 | 20 | 51 | 230 | 43 | 34 | ||||
II–IV | 25 | 14 | 48 | 13 | 12 | 18 | 44 | 25 | 8 | 54 | 57 | 16 | 14 | ||||
Aberrant p53 expression | <0.001 | <0.001 | <0.001 | 0.162 | |||||||||||||
Yes | 12 | 8 | 28 | 11 | 1 | 5 | 31 | 12 | 3 | 33 | 37 | 9 | 2 | ||||
No | 213 | 42 | 54 | 174 | 39 | 41 | 55 | 213 | 23 | 73 | 216 | 48 | 45 |